NCT00759356View on ClinicalTrials.gov

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions
Healthy
Interventions
DRUG

morphine sulfate sustained-release capsules

1 x 200 mg, single-dose capsule

DRUG

KADIAN

2 x 100 mg, single-dose capsule

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00759356 - Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions | Biotech Hunter | Biotech Hunter